Futures are flat as investors await another big batch of earnings reports. Here’s what we’re watching ahead of Wednesday’s action:
-
shares plunged 21% premarket after Politico reported that the pharmaceutical company was running into difficulties manufacturing a Covid-19 vaccine that met regulators’ quality standards. Fellow vaccine maker
added 1.6%.
A scientist at Novavax worked at a purification machine at the Novavax offices in Gaithersburg, Md., Feb. 11, 2021.
Photo:
T.J. Kirkpatrick for The Wall Street journal
-
slipped 2.4% ahead of the bell. The streaming giant added 4.4 million memberships in the third quarter amid increased competition and the typical summer slowdown.
-
whose profit was boosted by federal aid, said the spread of the highly transmissible strain of Covid-19 slowed flying during the third quarter but hasn’t derailed its recovery. Its shares added 1.9% premarket.
-
and
are due to report before the opening bell.
-
slipped 1.3% premarket. The advertising company said its business continued to improve from the damage caused by the pandemic, with third-quarter organic revenue gains in each of its major disciplines.
-
gained 3.3%. The rail operator’s profit increased in the third quarter, helped by higher freight rates and a rise in some fuel surcharges.
-
slipped 0.9% premarket. The electronic broker reported a decline in earnings per share for the recent quarter compared with a year ago.
-
CSX,
and
are among the companies reporting earnings after the close.
Chart of the Day
- The launch of ProShares Bitcoin Strategy ETF is being closely watched on Wall Street, where finding a way to sell securities linked to bitcoin has been a priority for many firms.
Write to James Willhite at james.willhite@wsj.com
Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More:Novavax, Tesla, Netflix, United: What to Watch When the Stock Market Opens Today
2021-10-20 10:44:00
